GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Price-to-Owner-Earnings

Novartis India (BOM:500672) Price-to-Owner-Earnings : 28.33 (As of May. 24, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India Price-to-Owner-Earnings?

As of today (2024-05-24), Novartis India's share price is ₹1105.80. Novartis India's Owner Earnings per Share (TTM) ended in Mar. 2024 was ₹39.03. It's Price-to-Owner-Earnings for today is 28.33.


The historical rank and industry rank for Novartis India's Price-to-Owner-Earnings or its related term are showing as below:

BOM:500672' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.32   Med: 17.97   Max: 90.13
Current: 27.93

During the past 13 years, the highest Price-to-Owner-Earnings of Novartis India was 90.13. The lowest was 7.32. And the median was 17.97.


BOM:500672's Price-to-Owner-Earnings is ranked worse than
50.6% of 419 companies
in the Drug Manufacturers industry
Industry Median: 27.45 vs BOM:500672: 27.93

As of today (2024-05-24), Novartis India's share price is ₹1105.80. Novartis India's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹34.50. Therefore, Novartis India's PE Ratio for today is 32.05.

As of today (2024-05-24), Novartis India's share price is ₹1105.80. Novartis India's EPS without NRI for the trailing twelve months (TTM) ended in was ₹34.54. Therefore, Novartis India's PE Ratio without NRI for today is 32.01.

During the past 13 years, Novartis India's highest PE Ratio without NRI was 153.38. The lowest was 8.90. And the median was 31.17.


Novartis India Price-to-Owner-Earnings Historical Data

The historical data trend for Novartis India's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Price-to-Owner-Earnings Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 72.34 - 21.02 16.98 26.36

Novartis India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.98 - - - 26.36

Competitive Comparison of Novartis India's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis India's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis India's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Novartis India's Price-to-Owner-Earnings falls into.



Novartis India Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Novartis India's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1105.80/39.03
=28.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novartis India  (BOM:500672) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Novartis India Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Novartis India's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis India (BOM:500672) Business Description

Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines